Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas
暂无分享,去创建一个
M. Widschwendter | M. Hermann | J. Bergelson | C. Marth | E. Müller-Holzner | A. Zeimet | A. Schuler | J. Berger | A. Zeimet | G. Hartung | M. Hermann | JM Bergelson
[1] G. Nemerow,et al. Integrin αvβ1 Is an Adenovirus Coreceptor , 2001, Journal of Virology.
[2] R. Kreienberg,et al. Adenoviral Transduction Efficiency of Ovarian Cancer Cells Can Be Limited by Loss of Integrin β3 Subunit Expression and Increased by Reconstitution of Integrin αvβ3 , 2001 .
[3] J. Dye,et al. Phenotype of the endothelium in the human term placenta. , 2001, Placenta.
[4] R. Kreienberg,et al. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. , 2001, Human gene therapy.
[5] M. Widschwendter,et al. New insights into p53 regulation and gene therapy for cancer. , 2000, Biochemical pharmacology.
[6] B. Hann,et al. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015) , 2000, Nature Medicine.
[7] L. Johnson,et al. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy , 2000, Nature Medicine.
[8] J. Bergelson,et al. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. , 2000, Cancer research.
[9] H. Abe,et al. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. , 2000, Journal of neurosurgery.
[10] A. Tamanini,et al. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.
[11] B. Neustadt,et al. Targeting Integrins αvβ3 and αvβ5 for Bloking Tumor-Induced Angiogenesis , 2000 .
[12] N. Hackett,et al. Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] B. Neustadt,et al. Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis. , 2000, Advances in experimental medicine and biology.
[14] S. Kim,et al. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. , 2000, The Journal of biological chemistry.
[15] D. Curiel,et al. Detection of Coxsackie–Adenovirus Receptor (CAR) Immunoreactivity in Ovarian Tumors of Epithelial Derivation , 1999 .
[16] R. Walker,et al. Integrins: a role as cell signalling molecules. , 1999, Molecular pathology : MP.
[17] Jhingook Kim,et al. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse , 1999, Cancer Gene Therapy.
[18] R. Crystal,et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. , 1999, The Journal of clinical investigation.
[19] A. Sagalowsky,et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. , 1999, Cancer research.
[20] R. Kreienberg,et al. p53 mutations and expression in ovarian cancers: correlation with overall survival. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[21] C. Miller,et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. , 1998, Cancer Research.
[22] C. Miller,et al. An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism , 1998, Journal of Virology.
[23] R. Dummer,et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. , 1998, Human gene therapy.
[24] G. Rodan,et al. The αvβ3 Integrin Regulates α5β1-mediated Cell Migration toward Fibronectin* , 1997, The Journal of Biological Chemistry.
[25] L. Duan,et al. Optimizing Suicide Gene Therapy for Head and Neck Cancer , 1997, The Laryngoscope.
[26] D. Curiel,et al. Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells , 1997, The EMBO journal.
[27] J. Rader,et al. Expression of αvβ3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas , 1997 .
[28] E. Maxwell,et al. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. , 1997, Cancer gene therapy.
[29] J. Bergelson,et al. Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.
[30] J. Rader,et al. Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. , 1997, Human pathology.
[31] D. Alberts,et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. , 1996, The New England journal of medicine.
[32] A. Fattaey,et al. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.
[33] Y. Denoux,et al. Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. , 1996, Gynecologic oncology.
[34] A. Monnier,et al. Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Jeffrey W. Smith,et al. A Biochemical Characterization of the Binding of Osteopontin to Integrins αvβ1 and αvβ5(*) , 1995, The Journal of Biological Chemistry.
[36] A. Passaniti,et al. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. , 1995, Cancer research.
[37] M. Rollence,et al. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain , 1995, Journal of virology.
[38] J. Roth,et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. , 1995, Cancer research.
[39] E. Oldfield,et al. Heterogeneity of subcellular localization of p53 protein in human glioblastomas. , 1994, Cancer research.
[40] G. Nemerow,et al. Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.
[41] W. Schleif,et al. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses , 1988, Journal of virology.